UNSPSC 51282302: Clarithromycin

This classification denotes a macrolide antibiotic with the molecular formula C38H69NO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H1250JIK0A, chemically known as erythromycin, 6-o-methyl- but generally known as clarithromycin, which bears US NIH Compound Identifier 54688. European Medicines Agency schedules Clarithromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06641MIG.

UNSPSC 51282302 Clarithromycin is a Commodity code that state and local governments use to tag pharmaceutical procurement, though recent opportunities show significant misalignment between the code's nominal scope and actual solicitation activity. The four recent state and local opportunities posted under or near this code span naloxone and drug deactivation systems (emergency response supplies), generic multi-source pharmaceuticals and OTC products (cooperative purchasing agreements), a therapeutic pharmacy initiative request for information, and medical and first aid supplies for fire rescue operations. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), municipal purchasing departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The work being solicited ranges from direct-to-manufacturer prescription fulfillment and competitive bidding for emergency medical consumables to framework agreements for pharmaceutical wholesaler distribution and exploratory vendor capability assessments.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building with a response deadline of July 26, 2023 (note: the source contains an apparent date inconsistency). The City of Tampa issued IFB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with sealed bids due March 13, 2026, an estimated contract value of $700,000, and a certified Small Local Business Enterprise set-aside with a 5 percent bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The Texas HHS Commission issued RFI HHS0017013 in April 2026 to assess vendor capacity for direct-to-manufacturer prescription programs serving self-insured employer and state agency health plans outside traditional pharmacy benefit manager arrangements.